Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors

This document (A57906) is an administrative 'Response to Comments' regarding the MolDX LCD DL38121 for next-generation sequencing in solid tumors, noting the comment period (05/30/2019–07/15/2019), notice period start (04/02/2020), and LCD effective date (05/17/2020). It does not contain clinical coverage criteria; reviewers should consult LCD DL38121 for specific indications, limitations, documentation requirements, and frequency limits.

"Administrative notice describing comment and notice periods for MolDX Next-Generation Sequencing for Solid Tumors LCD DL38121: comment period 05/30/2019–07/15/2019; notice period begins 04/02/2020;..."

Sign up to see full coverage criteria, indications, and limitations.